These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33932111)

  • 1. Expression and ERG regulation of PIM kinases in prostate cancer.
    Eerola SK; Kohvakka A; Tammela TLJ; Koskinen PJ; Latonen L; Visakorpi T
    Cancer Med; 2021 May; 10(10):3427-3436. PubMed ID: 33932111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.
    He HC; Bi XC; Zheng ZW; Dai QS; Han ZD; Liang YX; Ye YK; Zeng GH; Zhu G; Zhong WD
    Med Oncol; 2009; 26(3):303-8. PubMed ID: 19003546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
    Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
    PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
    Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
    Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of pim-1 mRNA in prostate cancer diagnosis.
    He HC; Bi XC; Dai QS; Wang SS; Wei HA; Zhong WD; Liu WH; Jiang FN; Liu LS
    Chin Med J (Engl); 2007 Sep; 120(17):1491-3. PubMed ID: 17908456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
    Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
    Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
    Furusato B; Tan SH; Young D; Dobi A; Sun C; Mohamed AA; Thangapazham R; Chen Y; McMaster G; Sreenath T; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):228-37. PubMed ID: 20585344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].
    Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
    Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PCA3 AND TMPRSS2:ERG GENES EXPRESSION IN BIOPSIES OF BENIGN PROSTATE HYPERPLASIA, INTRAEPITHELIAL NEOPLASIA, AND PROSTATE CANCER].
    Mikhaylenko DS; Perepechin DV; Grigoryeva MV; Zhinzhilo TA; Safronova NY; Efremov GD; Sivkov AV
    Urologiia; 2015; (5):46-50. PubMed ID: 26859937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
    He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
    Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
    Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
    J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.
    Robert G; Jannink S; Smit F; Aalders T; Hessels D; Cremers R; Mulders PF; Schalken JA
    Prostate; 2013 Jan; 73(2):113-20. PubMed ID: 22674214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
    Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.
    Teng LH; Wang C; Bégin LR; Dolph M; Yilmaz A; Trpkov K; Donnelly B; Bismar TA
    Urology; 2013 Aug; 82(2):394-9. PubMed ID: 23746715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.
    Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A
    PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.
    Blee AM; Liu S; Wang L; Huang H
    Oncotarget; 2016 Jun; 7(25):38319-38332. PubMed ID: 27223260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer.
    Kristensen G; Røder MA; Berg KD; Elversang J; Iglesias-Gato D; Moreira J; Toft BG; Brasso K
    APMIS; 2018 Oct; 126(10):804-813. PubMed ID: 30191621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.